PK11007
CAS: 38275-34-2
Ref. 3D-NBA27534
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire |
Product Information
- 5-Chloro-2-(methylsulfonyl)-4-pyrimidinecarboxylicacid
PK11007 is a novel anticancer drug that has been shown to have an anti-cancer effect on breast cancer cell lines. PK11007 binds to DNA and inhibits the transcriptional regulation of genes. It also has been shown to be a predictive biomarker for prognosis, as well as being sensitive to changes in cellular environment. This drug is synthesized from the secondary metabolite dibenzo[a,j]pyrene-7,8-diol, which is found in Astragalus membranaceus. The synthesis method involves the use of palladium catalyzed reductive amination and oxidation of dibenzo[a,j]pyrene-7,8-diol with sodium sulfide.
Chemical properties
Technical inquiry about: 3D-NBA27534 PK11007
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
